Search research articles
Contact Us
Filters
Showing results (41-50 of 43) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 43 results.
Leukemia
|
February 13, 2014
A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity
H Eda, L Santo, D D Cirstea, et al.
Oncogene
|
January 27, 2010
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition
L Santo, S Vallet, T Hideshima, et al.
Current Pharmaceutical Biotechnology
|
March 10, 2016
Innovative Immobilization Matrices
Gisela S Alvarez, Maria I A Echazu, Jessica A Bertinatto, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 43) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 43 results.
Leukemia
|
February 13, 2014
A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity
H Eda, L Santo, D D Cirstea, et al.
Oncogene
|
January 27, 2010
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition
L Santo, S Vallet, T Hideshima, et al.
Current Pharmaceutical Biotechnology
|
March 10, 2016
Innovative Immobilization Matrices
Gisela S Alvarez, Maria I A Echazu, Jessica A Bertinatto, et al.
Page
of 5